| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |